Drug details

Soliqua Injection (insulin glargine and lixisenatide)

type of Antidiabetics, Long-Acting Insulins, Antidiabetics, Glucagon-like Peptide-1 Agonists

Soliqua 100/33 (insulin glargine and lixisenatide injection) is a combination of a long-acting human insulin analog with a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) or lixisenatide.

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • nausea,
  • loss of appetite,
  • itching,
  • yellowing of the skin or eyes (jaundice)
  • rash,
  • vomiting,
  • fever,
  • lightheadedness,
  • confusion,
  • chills,
  • tiredness,
  • dizziness,
  • blurred vision,
  • weakness, and
  • constipation,
  • dry mouth,
  • headache,
  • fatigue,
  • sweating,
  • cough,
  • noisy breathing,
  • tightness in the chest,
  • agitation,
  • little or no urination,
  • increased thirst,
  • increased urination,
  • fruit-like breath odor,
  • irregular heartbeat,
  • loss of consciousness,
  • rapid weight gain,
  • hostility,
  • slurred speech,
  • irritability,
  • trouble breathing,
  • nightmares,
  • indigestion,
  • unexplained weight loss,
  • difficulty swallowing,
  • cold sweats,
  • bloating,
  • convulsions,
  • coma,
  • muscle twitching,
  • cool or pale skin,
  • flushed, dry skin,
  • muscle pain or cramps,
  • increased hunger,
  • fast or weak heartbeat,
  • clammy skin,
  • abdominal or stomach pain,
  • numbness or tingling in the hands, feet, or lips,
  • abdominal pain radiating to the back,
  • swelling of the eyelids or around the eyes, face, lips, or tongue,
  • stupor,
The following drugs are related to Soliqua Injection, either as a replacement or used together:
  • Precose (acarbose)
  • Adlyxin (lixisenatide injection)
  • Avandia (rosiglitazone maleate)
  • Proglycem (diazoxide capsules)
  • Humalog (insulin lispro (human analog))
  • Humalog 75-25 (75-25 insulin lispro suspension and 25 insulin lispro injection)
  • NovoLog (insulin aspart [rdna origin] inj)
  • Lantus (insulin glargine [rdna origin] injection)
  • Janumet (sitagliptin metformin hcl)
  • Janumet XR (sitagliptin and metformin hcl)
  • Victoza (liraglutide [rdna] injection)
  • Symlin (pramlintide acetate injection)
  • Prandin (repaglinide)